Federal Register #2026-08595

DEA Rule Establishes Specific Listing and Drug Code for HHC as Schedule I Substance

This notice from the Drug Enforcement Administration (DEA) announces an administrative rulemaking action: - The DEA, under the Justice Department, is establishing a specific listing and DEA Controlled Substances Code Number for hexahydrocannabinol (HHC) as a Schedule I controlled substance - HHC was previously controlled under the broader drug code 7370 for tetrahydrocannabinols - The new rule assigns HHC its own DEA drug code for improved quota management for DEA-registered manufacturers - No products, services, vendors, or OEMs are involved - No procurement, quantities, or part numbers are specified - This is an administrative update and does not alter the legal status of HHC - No unique procurement requirements are present

Description

The Drug Enforcement Administration (DEA) is establishing a specific listing and DEA Controlled Substances Code Number for hexahydrocannabinol (HHC) in schedule I of the Controlled Substances Act (CSA). Although HHC is currently controlled under drug code 7370 as a tetrahydrocannabinol, this rule amends the schedule I hallucinogenic substances list to separately include hexahydrocannabinol. The rule is effective May 4, 2026, and does not change the controlled status of HHC but allows for specific quota management.

View original listing